Last edition
News about "InMed Pharmaceuticals"
InMed Pharmaceuticals and Mentari Therapeutics Mergers to Advance Next-Generation Migraine Therapies
InMed Pharmaceuticals and Mentari Therapeutics have entered into a definitive merger agreement, combining Mentari’s migraine-focused drug pipeline with InMed’s public market infrastructure to support the development of innovative therapies targeting chronic and episodic migraine.
InMed Pharmaceuticals | 20/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members